TNF Blockers News and Research

RSS
Health Canada approves Simponi (golimumab) for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

Health Canada approves Simponi (golimumab) for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

Vitamin D deficiency is associated with inflammation in healthy women

Vitamin D deficiency is associated with inflammation in healthy women

Trial of new biologic agent to treat psoriatic arthritis

Trial of new biologic agent to treat psoriatic arthritis

Paradigm shift in the regulation of immune response

Paradigm shift in the regulation of immune response

Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint

Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint

Mice with "superhealing" powers provide clues to treating arthritis caused by traumatic injury

Mice with "superhealing" powers provide clues to treating arthritis caused by traumatic injury

New approaches to prevent transplant rejection

New approaches to prevent transplant rejection

Gene therapy used to treat periodontal disease

Gene therapy used to treat periodontal disease

Rituxan in combination with chemo improves survival in chronic lymphocytic leukemia

Rituxan in combination with chemo improves survival in chronic lymphocytic leukemia

Vitamin E supplementation may reduce inflammation in the brain

Vitamin E supplementation may reduce inflammation in the brain

Better management of arthritis more important than new drugs

Better management of arthritis more important than new drugs

MorphoSys granted U.S. patent on antibodies against GM-CSF to treat inflammatory disorders

MorphoSys granted U.S. patent on antibodies against GM-CSF to treat inflammatory disorders

Soviet-developed immune formula boosts immune activity

Soviet-developed immune formula boosts immune activity

Musculoskeletal Center wins $2.2 million to study biologics safety

Musculoskeletal Center wins $2.2 million to study biologics safety

Adalimumab therapy may reduce health-care costs for Crohn's disease patients

Adalimumab therapy may reduce health-care costs for Crohn's disease patients

Cimzia study shows reduction of symptoms and progression of rheumatoid arthritis

Cimzia study shows reduction of symptoms and progression of rheumatoid arthritis

New drug combo stops rheumatoid arthritis in its tracks

New drug combo stops rheumatoid arthritis in its tracks

First-ever international guidelines for the treatment of psoriatic arthritis

First-ever international guidelines for the treatment of psoriatic arthritis

FDA grants orphan drug status to Reata's pancreatic cancer drug

FDA grants orphan drug status to Reata's pancreatic cancer drug

FDA forces manufacturers of TNF-blockers to highlight risk of fungal infections

FDA forces manufacturers of TNF-blockers to highlight risk of fungal infections